Company Filing History:
Years Active: 2015-2018
Title: Gaëtan Otto: Innovator in Cancer Detection and Treatment
Introduction
Gaëtan Otto is a notable inventor based in Sart-Tilman, Belgium. He has made significant contributions to the field of cancer detection and treatment through his innovative methods and technologies. With a total of two patents to his name, Otto's work focuses on improving the diagnosis and treatment of various cancers.
Latest Patents
Otto's latest patents include methods for amplifying DNA from the promoter of the NDRG4 gene obtained from fecal samples. One of his inventions involves detecting a predisposition to cancer by identifying epigenetic changes in specific genes. These genes include members of the NDRG4/NDRG2 subfamily, GATA4, OSMR, GATA5, and several others. The detection of these changes can indicate a predisposition to cancer or its incidence. Additionally, he has developed pharmacogenetic methods for determining suitable treatment regimens for cancer patients. His inventions also encompass improved methods for collecting, processing, and analyzing body fluid samples, which can be instrumental in diagnosing and characterizing various diseases, particularly gastrointestinal cancers.
Career Highlights
Throughout his career, Gaëtan Otto has worked with prominent companies in the healthcare sector, including MDxHealth and Exact Sciences Development Company, LLC. His experience in these organizations has allowed him to refine his expertise in cancer diagnostics and treatment methodologies.
Collaborations
Otto has collaborated with notable professionals in his field, including Manon Van Engeland and Manon Adriaan De Bruine. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Gaëtan Otto's work in cancer detection and treatment exemplifies the impact of innovative thinking in the medical field. His patents and collaborations highlight his commitment to improving patient outcomes through advanced diagnostic methods.